{"name":"NeuroPro Therapeutics, Inc.","slug":"neuropro-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBOdmVrdXhpenEwekdvbjdVU3BMX25BNHE5NERjbUFtRGtlUWVwZklQLXNHSklCMFRfb0VhQUtRdVRYUmlUNk5oS3F0LUdLbjBLV211bEUxMV85VXFNdDl2UFBDX05fRkplNGl5elYzZXFUM3RxN1Atdw?oc=5","date":"2026-01-15","type":"pipeline","source":"neurologytoday.aan.com","summary":"AAN Releases First Guidelines for Managing Functional Seizures - neurologytoday.aan.com","headline":"AAN Releases First Guidelines for Managing Functional Seizures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9vNllnQ19pRmhEZXB2NTVKYVBkemxJaWh3WjVOeWV4MVBRY05Bb1U5cGxJNk9IM3VCU081SE5fcXlCT0RQTktiQ01aVVZjbWh6NGxBbWFzQU5wT3NjeEdRTFFjWGYxUGhWWkZUaURNZjNqSjhPZTZpeA?oc=5","date":"2026-01-02","type":"pipeline","source":"neurologytoday.aan.com","summary":"Fathers' Use of Valproate Raises Risk of Neurodevelopmental Disorders in Offspring - neurologytoday.aan.com","headline":"Fathers' Use of Valproate Raises Risk of Neurodevelopmental Disorders in Offspring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOTHU3a2hkd0pfbFRJSDI3TTZkSlFMNWxBaTJyYzlod1V6aTdHQkI2VGFSVUtjXzYxN2NYOFA2UVBJV2NpOWhPYTlibTN0UWswbGdCby1VOU5BYWVWYjVvaXZ3aW9TQndEZWsyQVpEai1sXy1Ha09aNVE0YWVxRFdNOUlSQQ?oc=5","date":"2025-10-20","type":"pipeline","source":"NYU Langone Health","summary":"Resistance to Epilepsy Treatments May Wane Over Time - NYU Langone Health","headline":"Resistance to Epilepsy Treatments May Wane Over Time","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPMW1jb1NCSnFLRVVINXFianoxbTd6Y1lFQ2RNNHJZVzYxb2JUczRzajdPc2d0RVQ2eDlZWENZZ1VSZkZBRUlJSGdKblFNU3ctbkV1MkI0aVdETFctUTZ6TVg0UldXaHVnWGxXcVlkaWdPNnIwa0VXRWN4cVJLYWstOXloQXIyaDNQcDAwYnRNQjVvN3AxaVdBaEt4MEhhT0MzQmc?oc=5","date":"2025-08-25","type":"pipeline","source":"NYU Langone Health","summary":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief - NYU Langone Health","headline":"Most Epilepsy Patients Wait a Year After Starting Treatment for Seizure Relief","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxQbkVOcGtkM1NsbWlxM2hSMzlRSm1Na1NLb1M1YjRxZGViYUdmVnNPQzBtQVdTckY1QmhsdXFBNlFBeTB3QmpWNk5xYUxTamdBQjBYcGpQaXluT3gwUUxjZjhMSWxiM1dCLUFNamR5NjAwTWhCWW1jdmNidUg2THZuWkEzOEt4bnlpdXBDSHdFZm9hMnVZSktZXzNsQVVNMm01N0hCMi1jaG1JWG5OWnhaaWY3bDBEVTM5WEx1ZC16eUZacE9OMUhTck80V0xOOUdFZzZWeU9aRGppV0hldVk2c2VwRk9IMGVaU01QaEF5LXp0SFFZYXN0ejR3WEFiQ1JlRkdVVWFLVmZqSTBJdHlNZmpFaktxOUwwcHg0bmJUSWVUWTVVWlpIMkluQ0tWLWFVQ0lLMjF1dw?oc=5","date":"2025-04-09","type":"trial","source":"GlobeNewswire","summary":"Sodium Channel Blockers Clinical Trial Pipeline Accelerates - GlobeNewswire","headline":"Sodium Channel Blockers Clinical Trial Pipeline Accelerates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPekJQS3B3R0kxcUJDRkxVUXRJS3pTWVBnZW9qWEQtT0Rtc2lCM3ZINXdLRTMzTlZHSEZIeEs2eXdGbW5leWZpSzBIUnlIWVNFVHVhczlCanM2QjBUWUhHeXNReTVlYU03dDlwZEN3d0lxVFRxN2dBZjFvQ1F1c19jODZNRFRHVk5LQUVWLWhaYXZxRl9oYVpDTEZud3lzdzNDUEdZR0xjai1DU2xuLWVwTmZxMzNmTS1xUmdaSWhqbWJ6ZnVDWnU2S3I5b2htNzJCdkdXemU3R29MQ0dicGltYkwyX0VHMDYyU1k1dmt6ZHhaYnl0WmIwcA?oc=5","date":"2025-02-05","type":"pipeline","source":"GlobeNewswire","summary":"Vielight Unveils Neuro Pro 2: The Most Advanced Transcranial Photobiomodulation Device to Date - GlobeNewswire","headline":"Vielight Unveils Neuro Pro 2: The Most Advanced Transcranial Photobiomodulation Device to Date","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQZVBLWDNSM1lQWUtIbFBxX3Z0VURQbjBIa0RVXzZWZkxWOWUta2NPZE1MRUdMZXpqM2Z4Qjl4cHJFUUhYWjdTcUJmYUJTeWFWdmxiVl9OcXR6dEpPZXVWWWNmQk5CRC1SVGhfS19nTlI2bl9qWGtGR3JxUlp4aHBtc1lwX0dDdjY2NDc1MnZ6Y0VOVnZSalNZRV8yUjJ5SVVBWVY1NE02OURLLXlKaUxkMkNreVozSjZ0QmdvLTJtOUtfcnhoMDZ0Yg?oc=5","date":"2023-11-08","type":"pipeline","source":"Healio","summary":"XEN1101 significantly reduced monthly seizures for adults with focal-onset epilepsy - Healio","headline":"XEN1101 significantly reduced monthly seizures for adults with focal-onset epilepsy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQS2VHSU42M3B1RXQ4bUJnT2xfRFdxcTFULTJYZndGMTlQT2dBaUp2R0daMzZXMHFPZU9vWDQ0a0dTME9OVmlQVkp2bTFKZ04xVng1TUNVbGY4MllHbURIcTNiV3hNZlpkR0E1U2FEZVZOaXFqbGYxN2h5RUpaOWp1MmszTFk3bW1tTXlCNnB1RVgyNncwY1Npend1ZlNrSS00QmhWcWFUZ1ppd1gzUk4tRW9LQzNpVzRxVmdpNzdObWhobnB5WE1KNmhiNGlRVkFCSEl2VHREVFd4SDBqQnBKSU5oMUVZTUZHQjNseVNmTndfUndUZUw4?oc=5","date":"2023-04-11","type":"pipeline","source":"prnewswire.com","summary":"DelveInsight Evaluates a Robust Epilepsy Pipeline as 70+ Influential Pharma Players to Set Foot in the Domain - prnewswire.com","headline":"DelveInsight Evaluates a Robust Epilepsy Pipeline as 70+ Influential Pharma Players to Set Foot in the Domain","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}